Lauren Wheeler
Medical · Lubbock, TXNPI 1386091775
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 1,286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Amgen at 25.1% of the total. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,286 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$6K
- AbbVie$4K
- UCB, Inc.$2K
- AstraZeneca$2K
- Novartis$2K
- GSK$2K
- plus $7K from 24 others
What the payments were for
- Food & beverage$25,17899%
- Education$1451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 365 | $6,361 |
| AbbVie(2 entities) | 202 | $4,274 |
| UCB, Inc. | 98 | $2,268 |
| AstraZeneca(2 entities) | 67 | $2,020 |
| Novartis | 112 | $1,742 |
| GSK | 79 | $1,662 |
| Johnson & Johnson(2 entities) | 75 | $1,602 |
| Lilly USA, LLC | 39 | $783 |
| Genentech USA, Inc. | 47 | $745 |
| E.r. Squibb & Sons, L.L.C. | 34 | $585 |
| Boehringer Ingelheim | 24 | $583 |
| Pfizer | 40 | $537 |
| ANI Pharmaceuticals, Inc. | 26 | $498 |
| Radius Health, Inc. | 29 | $473 |
| Mallinckrodt Hospital Products Inc. | 10 | $399 |
| Daiichi Sankyo Inc. | 9 | $150 |
| Sanofi | 4 | $140 |
| Sandoz | 5 | $110 |
| Janssen Scientific Affairs, LLC | 2 | $98 |
| Pacira Therapeutics, Inc. | 4 | $55 |
| Organon | 5 | $43 |
| Mylan Institutional Inc. | 2 | $37 |
| Sobi, Inc | 1 | $35 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Bioventus LLC | 1 | $18 |
| Alvogen Inc | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Tersera Therapeutics LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,323 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 83 | $592,062 |
| RinvoqUpadacitinib | 49 | $371,284 |
| Enbrel SureclickEtanercept | 43 | $345,674 |
| Orencia ClickjectAbatacept | 41 | $231,637 |
| OtezlaApremilast | 33 | $156,106 |
| Humira(Cf)Adalimumab | 11 | $99,700 |
| OrenciaAbatacept | 11 | $71,982 |
| KevzaraSarilumab | 15 | $63,288 |
| RayosPrednisone | 17 | $45,043 |
| Hydroxychloroquine Sulfate | 711 | $26,349 |
| MethotrexateMethotrexate Sodium | 639 | $13,803 |
| Duloxetine Hcl | 393 | $8,894 |
| Mycophenolate Mofetil | 54 | $7,598 |
| Celecoxib | 202 | $5,874 |
| Gabapentin | 277 | $5,403 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Humira(Cf) | $4,274 | $470,98460 claims |
| AmgenOtezla, Rayos | $6,361 | $201,15050 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $585 | $71,98211 claims |
| SanofiKevzara | $140 | $63,28815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,490 medical providers in Texas.
Other medical in Lubbock
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
- Radha BernanderKaty$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.